Axin1 expression facilitates cell death induced by aurora kinase inhibition through PARP activation

Journal of Cellular Biochemistry

Volumn 112, Issue 9, 2011, Pages 2392-2402

  Choi, Eun Jin ^a   Kim, Shi Mun ^a   Song, Ki Joon ^a   Lee, Jae Myun ^b   Kee, Sun Ho ^a  

^a Korea University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

AIF; Aurora kinase; Axin; Cell death; PARP

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOSIS INDUCING FACTOR; AURORA KINASE INHIBITOR; AXIN; AXIN1; AXIN2; CASPASE 3; CELL PROTEIN; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL MEMBRANE; CELL SURVIVAL; CHROMATIN CONDENSATION; CONTROLLED STUDY; MEMBRANE RUPTURE; MITOCHONDRION; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84860400051     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23162     Document Type: Article

References (49)

1. Alano CC, Kauppinen TM, Valls AV, Swanson RA,. 2006. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA 103: 9685-9690. (Pubitemid 43955885)
2. Behrens J, Jerchow B-A, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W,. 1998. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3. Science 280: 596-599.
3. Chia IV, Costantini F,. 2005. Mouse Axin and Axin2/Conductin proteins are functionally equivalent in vivo. Mol Cell Biol 25: 4371-4376. (Pubitemid 40705744)
4. Cregan SP, Fortin A, MacLaurin JG, Callaghan SM, Cecconi F, Yu S-W, Dawson TM, Dawson VL, Park DS, Kroemer G, Slack RS,. 2002. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 158: 507-517. (Pubitemid 34851709)
5. Curry J, Angove H, Fazal L, Lyons J, Reule M, Thompson N, Wallis N,. 2009. Aurora B kinase inhibition in mitosis: Strategies for optimising the use of aurora kinase inhibitors such as AT9283. Cell Cycle 8: 1921-1929.
6. Ditchfield C, Johnson VL, Tighe A, Ellston R, Haworth C, Johnson T, Mortlock A, Keen N, Taylor SS,. 2003. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 161: 267-280. (Pubitemid 36529846)
7. Dreier MR, Grabovich AZ, Katusin JD, Taylor WR,. 2009. Short and long-term tumor cell responses to Aurora kinase inhibitors. Exp Cell Res 315: 1085-1099.
8. Fu J, Bian M, Jiang Q, Zhang C,. 2007. Roles of aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 5: 1-10.
9. Fumoto K, Kadono M, Izumi N, Kikuchi A,. 2009. Axin localizes to the centrosome and is involved in microtubule nucleation. EMBO Rep 10: 606-613.
10. Gao C, Chen Y-G,. 2010. Dishevelled: The hub of Wnt signaling. Cell Signal 22: 717-727.
11. Girdler F, Gascoigne KE, Eyers PA, Hartmuth S, Crafter C, Foote KM, Keen NJ, Taylor SS,. 2006. Validating Aurora B as an anti-cancer drug target. J Cell Sci 119: 3664-3675. (Pubitemid 44501870)
12. Gizatullin F, Yao Y, Kung V, Harding MW, Loda M, Shapiro GI,. 2006. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 66: 7668-7677. (Pubitemid 44289225)
13. Hadjihannas MV, Bruckner M, Jerchow B, Birchmeier W, Dietmaier W, Behrens J,. 2006. Aberrant Wnt/β-catenin signaling can induce chromosomal instability in colon cancer. Proc Natl Acad Sci USA 103: 10747-10752. (Pubitemid 44078047)
14. Hadjihannas MV, Bruckner M, Behrens J,. 2010. Conductin/axin2 and Wnt signalling regulates centrosome cohesion. EMBO Rep 11: 317-324.
15. Han Y, Wang Y, Xu H-T, Yang L-H, Wei Q, Liu Y, Zhang Y, Zhao Y, Dai S-D, Miao Y, Yu J-H, Zhang J-Y, Li G, Yuan X-M, Wang E-H,. 2009. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression. Int J Radiat Oncol Biol Phys 75: 518-526.
16. Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, Graham JA, Demur C, Hercend T, Diu-Hercend A, Su M, Golec JMC, Miller KM,. 2004. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med 10: 262-267. (Pubitemid 38667616)
17. Heeres JT, Hergenrother PJ,. 2007. Poly(ADP-ribose) makes a date with death. Curr Opin Chem Biol 11: 644-653. (Pubitemid 350180567)
18. Hoar K, Chakravarty A, Rabino C, Wysong D, Bowman D, Roy N, Ecsedy JA,. 2007. MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy. Mol Cell Biol 27: 4513-4525. (Pubitemid 46906573)
19. Huang S-MA, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, Hild M, Shi X, Wilson CJ, Mickanin C, Myer V, Fazal A, Tomlinson R, Serluca F, Shao W, Cheng H, Shultz M, Rau C, Schirle M, Schlegl J, Ghidelli S, Fawell S, Lu C, Curtis D, Kirschner MW, Lengauer C, Finan PM, Tallarico JA, Bouwmeester T, Porter JA, Bauer A, Cong F,. 2009. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614-620.
20. Itoh K, Krupnik VE, Sokol SY,. 1998. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin. Curr Biol 8: 591-594. (Pubitemid 28222894)
21. Jeon SH, Yoon J-Y, Park Y-N, Jeong W-J, Kim S, Jho E-H, Surh Y-J, Choi K-Y,. 2007. Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via β-catenin. J Biol Chem 282: 14482-14492. (Pubitemid 47100480)
22. Katayama H, Sasai K, Kawai H, Yuan Z-M, Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA, Sen S, 2004. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 36: 55-62. (Pubitemid 38056208)
23. Kim S-M, Choi E-J, Song K-J, Kim S, Seo E, Jho E-H, Kee S-H,. 2009. Axin localizes to mitotic spindles and centrosomes in mitotic cells. Exp Cell Res 315: 943-954.
24. Koh DW, Dawson TM, Dawson VL,. 2005. Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 52: 5-14. (Pubitemid 40725595)
25. Kojima K, Konopleva M, Tsao T, Nakakuma H, Andreeff M,. 2008. Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia. Blood 112: 2886-2895.
26. Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER,. 2002. Activation of AXIN2 expression by β-catenin-T cell factor. J Biol Chem 277: 21657-21665.
27. Li JJ, Li SA,. 2006. Mitotic kinases: The key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis. Pharmacol Ther 111: 974-984. (Pubitemid 44137383)
28. Li Q, Wang X, Wu X, Rui Y, Liu W, Wang J, Wang X, Liou Y-C, Ye Z, Lin S-C,. 2007. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death. Cancer Res 67: 66-74. (Pubitemid 46142760)
29. Li Q, Lin S, Wang X, Lian G, Lu Z, Guo H, Ruan K, Wang Y, Ye Z, Han J, Lin S,. 2009. Axin determines cell fate by controlling the p53 activation threshold after DNA damage. Nat Cell Biol 11: 1128-1134.
30. Li M, Jung A, Ganswindt U, Marini P, Friedl A, Daniel PT, Lauber K, Jendrossek V, Belka C,. 2010. Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways. Biochem Pharmacol 79: 122-129.
31. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, Herceg Z, Wang Z-Q,., Schulze-Osthoff K,. 2002. Activation and caspase-mediated inhibition of PARP: A molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 13: 978-988. (Pubitemid 34250359)
32. Lu J, Zhang F, Zhao D, Hong L, Min J, Zhang L, Li F, Yan Y, Li H, Ma Y, Li Q,. 2008. ATRA-inhibited proliferation in glioma cells is associated with subcellular redistribution of beta-catenin via up-regulation of Axin. J Neurooncol 87: 271-277.
33. Margolis RL, Lohez OD, Andreassen PR,. 2003. G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 88: 673-683. (Pubitemid 36258817)
34. Neo SY, Zhang Y, Yaw LP, Li P, Lin S-C,. 2000. Axin-induced apoptosis depends on the extent of its JNK activation and its ability to down-regulate [beta]-catenin levels. Biochem Biophys Res Commun 272: 144-150. (Pubitemid 30444913)
35. Papeo G, Forte B, Orsini P, Perrera C, Posteri H, Scolaro A, Montagnoli A,. 2009. Poly(ADP-ribose) polymerase inhibition in cancer therapy: Are we close to maturity? Expert Opin Ther Pat 19: 1377-1400.
36. Sakanaka C, Weiss JB, Williams LT,. 1998. Bridging of β-catenin and glycogen synthase kinase-3β by Axin and inhibition of β-catenin- mediated transcription. Proc Natl Acad Sci USA 95: 3020-3023. (Pubitemid 28135847)
37. Salahshor S, Woodgett JR,. 2005. The links between axin and carcinogenesis. J Clin Pathol 58: 225-236. (Pubitemid 40380314)
38. Singh MH, Brooke SM, Zemlyak I, Sapolsky RM,. 2010. Evidence for caspase effects on release of cytochrome c and AIF in a model of ischemia in cortical neurons. Neurosci Lett 469: 179-183.
39. Tarnawski A, Pai R, Chiou SK, Chai J, Chu EC,. 2005. Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B. Biochem Biophys Res Commun 334: 207-212. (Pubitemid 40978527)
40. Tong T, Zhong Y, Kong J, Dong L, Song Y, Fu M, Liu Z, Wang M, Guo L, Lu S, Wu M, Zhan Q,. 2004. Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin Cancer Res 10: 7304-7310. (Pubitemid 39487719)
41. Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P,. 1998a. Inhibition of caspases increases the sensitivity of L929cells to necrosis mediated by tumor necrosis factor. J Exp Med 187: 1477-1485. (Pubitemid 28215406)
42. Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W, Vandenabeele P,. 1998b. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways. J Exp Med 188: 919-930. (Pubitemid 28433418)
43. Vischioni B, Oudejans JJ, Vos W, Rodriguez JA, Giaccone G,. 2006. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol Cancer Ther 5: 2905-2913. (Pubitemid 44849018)
44. Wang Y, Dawson VL, Dawson TM,. 2009. Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos. Exp Neurol 218: 193-202.
45. Willert K, Shibamoto S, Nusse R,. 1999. Wnt-induced dephosphorylation of Axin releases β-catenin from the Axin complex. Genes Dev 13: 1768-1773. (Pubitemid 29353044)
46. Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M, Kikuchi A,. 1998. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3β and β-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol 18: 2867-2875. (Pubitemid 28183455)
47. Yang H, Burke T, Dempsey J, Diaz B, Collins E, Toth J, Beckmann R, Ye X,. 2005. Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase. FEBS Lett 579: 3385-3391. (Pubitemid 40800286)
48. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F,. 1997. The mouse fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181-192. (Pubitemid 28009429)
49. Zhang D, Hirota T, Marumoto T, Shimizu M, Kunitoku N, Sasayama T, Arima Y, Feng L, Suzuki M, Takeya M, Saya H,. 2004. Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 23: 8720-8730. (Pubitemid 39593287)